Isabelle Ingemansson

Isabelle Ingemansson is an accomplished medical professional with extensive experience in healthcare and medical innovation. Currently serving as a Research Assistant at Sahlgrenska Universitetssjukhuset since June 2022 and as CEO of OTII health since October 2022, Isabelle has also held various roles including AT-läkare and Underläkare at VaccinDirekt and Sahlgrenska University Hospital. With a background as a Healthcare Innovation Consultant at DAYA and leadership as Chair of the AT Committee for Medical Innovation & Technology, Isabelle possesses a strong foundation in medical and scientific research. Educationally, Isabelle holds a medical degree from the University of Gothenburg and has completed secondary education with a science focus at Polhemskolan in Lund. Additional international experience includes studies at Colegio Escandinavo in Madrid.